Takemoto Fumi, Shinki Toshimasa, Yokoyama Keitaro, Inokami Taketoshi, Hara Shigeko, Yamada Akira, Kurokawa Kiyoshi, Uchida Shunya
Kidney Center, Toranomon Hospital, Tokyo, Japan.
Kidney Int. 2003 Aug;64(2):414-20. doi: 10.1046/j.1523-1755.2003.00114.x.
Regulation of vitamin D hydroxylase genes in the early stage of chronic renal failure is not fully understood. Using nephrectomized rats, we examined changes in mRNA levels of CYP27B1 (25-hydroxyvitamin D3-1 alpha-hydroxylase), CYP24 (25-hydroxyvitamin D3-24-hydroxylase), and vitamin D receptor in relation to megalin, recently found to participate in renal vitamin D metabolism.
A rat model of moderate renal failure was induced by 3/4 nephrectomy. Plasma parameters, including vitamin D metabolite concentrations, were measured at weeks 2, 4 and 8, and poly(A)+ RNA extracted from the remnant kidneys was subjected to Northern blot hybridization.
Plasma creatinine concentration at week 2 was 0.40 +/- 0.02 mg/dL in the sham-operated and 0.93 +/- 0.15 mg/dL in the nephrectomized rats, and both values remained constant up to week 8. Plasma concentrations of 25(OH)D3, 1 alpha,25(OH)2D3, and 24,25(OH)2D3 were unchanged between nephrectomized and sham-operated rats at week 8. Intact parathyroid hormone (PTH) increased at week 8 in nephrectomized rats. CYP27B1 mRNA in nephrectomized rats did not vary at week 2, but increased approximately two- and four-fold at weeks 4 and 8, respectively, compared to the sham-operated rats. CYP24 and megalin mRNAs, on the other hand, began to decline as early as at week 2 in nephrectomized rats and kept decreasing throughout the experiment. The expression of vitamin D receptor was modestly but significantly decreased only at week 8.
Coordinated and reciprocal alterations of the increase in CYP27B1 mRNA and the decrease in CYP24 mRNA may play a pivotal role in maintaining the plasma level of 1 alpha,25(OH)2D3 in the face of reduced nephron mass and/or megalin expression.
慢性肾衰竭早期维生素D羟化酶基因的调控机制尚未完全明确。我们利用肾切除大鼠模型,研究了细胞色素P450 27B1(25-羟维生素D3-1α-羟化酶)、细胞色素P450 24(25-羟维生素D3-24-羟化酶)的mRNA水平变化以及维生素D受体与巨膜蛋白(最近发现其参与肾脏维生素D代谢)之间的关系。
通过3/4肾切除建立中度肾衰竭大鼠模型。在第2、4和8周测量血浆参数,包括维生素D代谢物浓度,并从残余肾脏中提取多聚腺苷酸(poly(A))+RNA进行Northern印迹杂交。
假手术组大鼠第2周血浆肌酐浓度为0.40±0.02mg/dL,肾切除组为0.93±0.15mg/dL,两者在第8周前均保持稳定。第8周时,肾切除组和假手术组大鼠血浆25(OH)D3、1α,25(OH)2D3和24,25(OH)2D3浓度无变化。肾切除组大鼠第8周时完整甲状旁腺激素(PTH)升高。肾切除组大鼠第2周时CYP27B1 mRNA无变化,但与假手术组相比,第4周和第8周分别增加了约两倍和四倍。另一方面,肾切除组大鼠早在第2周时CYP24和巨膜蛋白mRNA就开始下降,并在整个实验过程中持续降低。维生素D受体的表达仅在第8周时适度但显著下降。
面对肾单位数量减少和/或巨膜蛋白表达降低的情况,CYP27B1 mRNA增加和CYP24 mRNA减少的协同和相互变化可能在维持血浆1α,25(OH)2D3水平方面起关键作用。